TY  - GEN
AU  - Langley,Richard G
AU  - Elewski,Boni E
AU  - Lebwohl,Mark
AU  - Reich,Kristian
AU  - Griffiths,Christopher E M
AU  - Papp,Kim
AU  - Puig,Lluís
AU  - Nakagawa,Hidemi
AU  - Spelman,Lynda
AU  - Sigurgeirsson,Bárður
AU  - Rivas,Enrique
AU  - Tsai,Tsen-Fang
AU  - Wasel,Norman
AU  - Tyring,Stephen
AU  - Salko,Thomas
AU  - Hampele,Isabelle
AU  - Notter,Marianne
AU  - Karpov,Alexander
AU  - Helou,Silvia
AU  - Papavassilis,Charis
TI  - Secukinumab in plaque psoriasis--results of two phase 3 trials
SN  - 1533-4406
PY  - 2014///0729
KW  - Adult
KW  - Antibodies
KW  - blood
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antibodies, Monoclonal, Humanized
KW  - Double-Blind Method
KW  - Etanercept
KW  - Female
KW  - Humans
KW  - Immunoglobulin A
KW  - Immunoglobulin G
KW  - Immunosuppressive Agents
KW  - Infections
KW  - etiology
KW  - Injections, Subcutaneous
KW  - Interleukin-17
KW  - antagonists & inhibitors
KW  - Male
KW  - Middle Aged
KW  - Psoriasis
KW  - drug therapy
KW  - Receptors, Tumor Necrosis Factor
KW  - therapeutic use
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1056/NEJMoa1314258
ER  -